Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4116 | OABIW OmniAb, Inc. - Warrant | 0.3900 USD | 0.00% | 0.00% | +6.12% | +160.00% | 56.70 M USD | ||
| 4119 | INKT MiNK Therapeutics, Inc. - Common Stock | 11.00 USD | -3.68% | -12.35% | -13.32% | 0.00% | 56.13 M USD | ||
| 4120 | GUTS Fractyl Health, Inc. - Common Stock | 4.23 USD | -6.42% | +861.36% | +531.34% | +200.00% | 56.11 M USD | ||
| 4125 | ATHE Alterity Therapeutics Limited - American Depositary Shares | 3.07 USD | -7.53% | -9.44% | -31.17% | -27.59% | 55.65 M USD | ||
| 4126 | CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 0.88 USD | -6.38% | -10.20% | -55.78% | -56.00% | 55.42 M USD | ||
| 4139 | LONA LeonaBio, Inc. - Common Stock | 5.75 USD | -1.37% | +32.49% | -19.47% | -14.69% | 54.17 M USD | ||
| 4141 | ACET Adicet Bio, Inc. - Common Stock | 5.74 USD | -7.12% | -14.33% | -39.32% | +523.91% | 53.73 M USD | ||
| 4151 | HYPD Hyperion DeFi, Inc. - Common Stock | 3.37 USD | -6.13% | -12.69% | -4.80% | -62.47% | 52.37 M USD | ||
| 4155 | DOMH Dominari Holdings Inc. - Common Stock | 2.15 USD | -0.46% | +2.38% | +11.40% | -65.82% | 52.12 M USD | ||
| 4156 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | 0.00% | +1.35% | +0.67% | +947.67% | 52.10 M USD | ||
| 4161 | CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 USD | -22.58% | -61.29% | -66.20% | -82.61% | 51.46 M USD | ||
| 4168 | SER Serina Therapeutics, Inc. Common Stock | 2.00 USD | -0.99% | +0.50% | -20.00% | +19.76% | 50.80 M USD | ||
| 4169 | INMB INmune Bio Inc. - Common stock | 1.83 USD | -1.61% | -5.67% | -24.69% | -7.58% | 50.79 M USD | ||
| 4172 | ANVS Annovis Bio, Inc. Common Stock | 1.18 USD | -1.67% | -0.84% | -2.48% | -27.16% | 50.28 M USD | ||
| 4178 | CRVO CervoMed Inc. - Common Stock | 3.28 USD | +3.14% | +10.81% | +31.20% | -61.82% | 49.59 M USD | ||
| 4194 | APLM Apollomics Inc. - Class A Ordinary Shares | 21.70 USD | +0.93% | -7.66% | -9.21% | +17.93% | 47.65 M USD | ||
| 4196 | ELTX Elicio Therapeutics, Inc. - Common Stock | 1.81 USD | -2.16% | -7.65% | -16.59% | -81.90% | 47.57 M USD | ||
| 4199 | CELU Celularity Inc. - Class A Common Stock | 1.46 USD | -0.68% | +2.10% | +1.39% | -32.09% | 47.38 M USD | ||
| 4203 | IMA ImageneBio, Inc. - Common Stock | 4.12 USD | -10.63% | -10.04% | -17.93% | -49.39% | 46.77 M USD | ||
| 4211 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 7.06 USD | +8.78% | +7.13% | -2.75% | +854.05% | 45.97 M USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |